Importantly, small-molecule and monoclonal antibody inhibitors of IGF1R potently decrease neuroblastoma cell viability and delay tumor growth in xenograft models of neuroblastoma [35,36,37,38,39,40,41,42,43,44]. This evidence concerns the gene IGF1R and neoplasm.